Copyright
©The Author(s) 2022.
World J Transplant. Oct 18, 2022; 12(10): 313-324
Published online Oct 18, 2022. doi: 10.5500/wjt.v12.i10.313
Published online Oct 18, 2022. doi: 10.5500/wjt.v12.i10.313
Table 4 Changes in T lymphocyte subpopulations at T0, T3, and T6 time points in patients with panel reactive antibodies (-)
| Parameter | T0 | T3 | T6 | P value |
| Lymphocyte, % | 18.8 (6.4-38.4) | 23 (10.9-47.9) | 25.4 (8.4-52) | 0.001 |
| Lymphocyte, cells/μL | 1200 (700-2800) | 1650 (700-4100) | 1900 (800-3700) | < 0.0001 |
| CD4+, % | 44.4 (20.6-68.6) | 49.8 (22.7-77.1) | 49.1 (16.2-71.4) | 0.004 |
| CD4+, cells/μL | 557 (206-1453.2) | 782 (261.8-1951.6) | 872 (330-2001.6) | < 0.0001 |
| CD8+, % | 25.1 (12.2-37.7) | 26.9 (12.4-50.1) | 27.4 (13.3-49) | NS |
| CD8+, cells/μL | 301.5 (102.9-641.7) | 456.3 (148.6-1402.8) | 514.5 (189.2-1397.8) | < 0.0001 |
| CD4CD28null, % | 4.8 (0.2-33.7) | 2.8 (0-21.1) | 2.7 (0.1-36.4) | NS |
| CD4CD28null, cells/μL | 26.7 (0.9-149) | 27.5 (0-160) | 26.5 (09-241) | NS |
| CD8CD28null, % | 38.3 (6.1-68.2) | 28.4 (8.3-80.5) | 32.8 (6.7-90.7) | NS |
| CD8CD28null, cells/μL | 113.6 (17-315) | 112.6 (28-1129) | 158 (18-1267) | NS |
| CD16/56, % | 17.7 (3.6-50.6) | 6.6 (1.9-24.2) | 9.3 (2.9-28.6) | < 0.0001 |
| CD16/56, cells/μL | 210 (50.4-750.5) | 121.6 (33-622.2) | 151.2 (44-774.4) | < 0.0001 |
| Tregs, %, on CD4 | 3.9 (0.1-11.5) | 3.3 (0.9-6.8) | 4.1 (1.4-8.8) | NS |
| Tregs, cells/μL | 20.2 (0.5-74.3) | 29.4 (7.5-122.9) | 38.4 (8-104) | < 0.0001 |
- Citation: Vagiotas L, Stangou M, Kasimatis E, Xochelli A, Myserlis G, Lioulios G, Nikolaidou V, Panteli M, Ouranos K, Antoniadis N, Maria D, Papagianni A, Tsoulfas G, Fylaktou A. Effect of panel reactive antibodies on T cell immunity reinstatement following renal transplantation. World J Transplant 2022; 12(10): 313-324
- URL: https://www.wjgnet.com/2220-3230/full/v12/i10/313.htm
- DOI: https://dx.doi.org/10.5500/wjt.v12.i10.313